Report Description

Global Therapeutic Drug Monitoring Market is projected to witness impressive growth during the forecast period. The worldwide healthcare industry's expansion is accelerating the demand for therapeutic medication monitoring. Therapeutic drug monitoring is a test that measures several medications in the bloodstream to verify the correct dosage of medication is being given. It checks to see whether there is enough to be useful and if there aren't any significant side effects or responses. Anti-arrhythmic, antibiotic, anti-epileptic, and psychotropic medications all require monitoring to guarantee their effectiveness and safety. TDM is commonly used for drugs that have a narrow therapeutic index, meaning that there is a small difference between a therapeutic dose and a toxic dose. Examples of such drugs include antibiotics, anticonvulsants, immunosuppressants, and anti-cancer drugs.

The rise in demand for hospital and medical care institutions across the globe acts as one of the major factors driving the growth of therapeutic drug monitoring market. The growing inclination for precision medicine and the significance of therapeutic drug monitoring (TDM) in organ transplant procedures both speed up market expansion. The therapeutic drug monitoring market is also positively impacted by changes in the medical sector, rising awareness, technical advancements, and a surge in pharmaceutical company investment. The growing awareness among healthcare professionals about the benefits of TDM is driving the market. Healthcare professionals are increasingly recognizing the importance of TDM in improving therapeutic outcomes and minimizing adverse effects. Additionally, the market players would benefit from increased use in the treatment of autoimmune illnesses during the projected period of 2024 to 2028.

Increasing prevalence of chronic diseases is driving the Market Expansion

The rising prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases, among others, is driving the demand for Therapeutic Drug Monitoring. Therapeutic Drug Monitoring is essential in managing these chronic conditions and ensuring that patients receive the right dose of medicationChronic diseases such as cancer, diabetes, and cardiovascular diseases require long-term management, and Therapeutic Drug Monitoring plays a critical role in optimizing drug therapy for these conditions. For instance, in cancer treatment, Therapeutic Drug Monitoring is used to ensure that the patient receives the optimal dose of chemotherapy while minimizing adverse effects. In diabetes management, Therapeutic Drug Monitoring is used to monitor blood glucose levels and adjust insulin doses accordingly. In cardiovascular diseases, Therapeutic Drug Monitoring is used to monitor the levels of anticoagulants and adjust the dose to prevent blood clots. The World Health Organization (WHO) reports that chronic diseases are the leading cause of mortality worldwide, and the prevalence of chronic diseases is increasing globally. The growing burden of chronic diseases is expected to increase the demand for Therapeutic Drug Monitoring in the coming years.

Therefore, the Therapeutic Drug Monitoring market is expected to grow as the prevalence of chronic diseases continues to increase, and Therapeutic Drug Monitoring becomes an essential tool in managing these conditions.

Advancements in technology fuel the Market Growth

Technological advancements in Therapeutic Drug Monitoring, such as the development of new assays and automated systems, are driving the market. These advancements have made Therapeutic Drug Monitoring more accurate, efficient, and cost-effective. For instance, new analytical techniques such as liquid chromatography-mass spectrometry (LC-MS) have improved the sensitivity and specificity of drug measurement, allowing for more accurate and precise drug monitoring. In addition, the development of point-of-care testing (POCT) devices has enabled rapid and convenient Therapeutic Drug Monitoring testing at the patient's bedside, reducing the time required to obtain drug concentration results and facilitating timely dose adjustments.

Automation and miniaturization of Therapeutic Drug Monitoring devices have also made the process more efficient and cost-effective. Automated Therapeutic Drug Monitoring systems reduce the need for manual labor and improve the accuracy and precision of drug concentration measurements. Miniaturization of Therapeutic Drug Monitoring devices allows for smaller sample sizes, reducing the amount of blood or other biological fluids required for testing, which is especially beneficial for pediatric or elderly patients. Overall, technological advancements in Therapeutic Drug Monitoring have improved the accuracy, efficiency, and cost-effectiveness of drug monitoring, leading to better patient outcomes. As technology continues to advance, the Therapeutic Drug Monitoring market is expected to grow further, driven by the demand for more accurate and efficient drug monitoring techniques.

Increased focus on cost-effectiveness of Therapeutic Drug Monitoring

The focus on cost-effectiveness in healthcare is driving the therapeutic drug monitoring market. Therapeutic drug monitoring can reduce healthcare costs by optimizing drug dosing and minimizing adverse effects, which can result in fewer hospitalizations and lower healthcare expenditures. Therapeutic drug monitoring can help to optimize drug therapy by monitoring drug concentrations in the patient's blood, ensuring that patients receive the right dose of medication while minimizing adverse effects. This can lead to better patient outcomes and reduced healthcare costs by preventing hospitalizations and other complications associated with suboptimal drug dosing. Moreover, therapeutic drug monitoring can reduce the length of hospital stays and decrease the number of laboratory tests required for patients, which can lead to cost savings. For example, in the case of antiretroviral therapy for HIV patients, therapeutic drug monitoring has been shown to be cost-effective by reducing the number of drug-resistant cases and the length of hospital stays.

As healthcare costs continue to rise globally, there is an increasing focus on cost-effectiveness in healthcare. Therapeutic drug monitoring is an effective tool to achieve this goal by reducing healthcare costs while improving patient outcomes. Therefore, the demand for therapeutic drug monitoring is expected to grow as healthcare providers and policymakers increasingly recognize its potential to reduce healthcare costs and improve patient outcomes.

Growing Research and Development along with clinical trials

The market is also influenced by the increased attention being paid to research and development projects relating to therapeutic drug monitoring (TDM) and the widespread use of the drug monitoring test in different therapeutic sectors. Increasing R&D efforts and clinical studies to broaden the use of technology in diverse indications, as well as rising rates of cancer, neurological disorders, HIV, autoimmune, and cardiac ailments. The Journal of Clinical Neurology reported in August 2021 that epilepsy, which affects over 70 million people globally, is the third most prevalent neurological condition after dementia and stroke.More than 55 million people will be living with dementia worldwide in 2021, estimates the WHO. Every year, there would be close to 10 million new cases reported. The most prevalent form of dementia, Alzheimer's disease, may be a factor in 60–70% of cases. Therefore, it is predicted that over the course of the projection period, rising risks of these diseases is anticipated to fuel therapeutic Drug Monitoring market expansion.

Use of Therapeutic Monitoring in Organ Transplant

Managing patients receiving solid-organ transplants requires conducting therapeutic drug monitoring for immunosuppressive medicines. Immunosuppressants are given to transplant recipients in order to prevent organ rejection by the body. Clinicians must tailor the immunosuppressant medication they give to each patient in order to strike the ideal balance between the likelihood of side effects and the efficacy of treatment. It can be tough to accomplish this goal with immunosuppressant therapy monitoring since patients have varied pharmacodynamics and pharmacokinetics. In addition, therapeutic Drug Monitoring can be used to monitor drug levels during the early post-transplant period when drug metabolism is highly variable, and drug levels can fluctuate rapidly. During this time, therapeutic Drug Monitoring can help to ensure that the patient receives the optimal dose of medication while minimizing adverse effects.

Overall, therapeutic Drug Monitoring plays a critical role in the management of organ transplant patients by optimizing drug therapy, preventing rejection of the transplanted organ, and minimizing adverse effects. therapeutic Drug Monitoring is widely used in organ transplant and is an essential tool to ensure the best possible outcomes for transplant patients.


Download Free Sample Report

Market Segmentation

The Global Therapeutic Drug Monitoring Market is segmented based on device type, class of devices, services. The device type segment is classified into IVD Devices, Diagnostic Imaging Devices, Cardiovascular Devices, Drug Delivery Devices, Orthopedic Devices, Respiratory Care Devices, Ophthalmology Devices, Surgical Devices, Diabetes Care Devices, Dental Devices, Endoscopy and Laparoscopy Devices, Gynecology and Urology Devices, Neurology Devices, Patient Monitoring Devices, Patient Assistive and Monitoring Devices, & Others. Based on class of devices the market is divided into Class I, Class II, Class III. Based on services the market is categorized into Device Development & Services, Quality Management Services, Packaging and Assembly Devices.

Recent Developments

  • At MEDICA 2021 in November 2021, Boditech Med unveiled their brand-new all-in-one cartridge system and automated immunoassay analyzer with a blood collection tube.
  • The Wyoming Board of Pharmacy and Bamboo Health, formerly Appriss Health and PatientPing, announced a partnership on June 29 in May 2022 to create a solution for the Wyoming Prescription Drug Monitoring Program (PDMP).

Market players

Roche AG, Siemens Healthcare GmbH, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., Abbott Laboratories, Inc., Agilent Technologies, Inc., bioMérieux, Inc., Alere, Inc.

Attribute

Details

Base Year

2022

Historic Data

2018 – 2021

Estimated Year

2023

Forecast Period

2024 – 2028

Quantitative Units

Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments covered

·         By Product

·         By Technology

·         By Class of Drug

·         By End- User

Regional scope

North America; Asia Pacific; Europe & CIS; South America; Middle East & Africa

Country scope

United States; Canada; Mexico; China; India; Japan; Australia; South Korea; Germany; France; United Kingdom; Spain; Italy; Brazil; Argentina; Colombia; South Africa; UAE, Saudi Arabia; Turkey; Egypt.

Key companies profiled

Roche AG, Siemens Healthcare GmbH,         Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., Abbott Laboratories, Inc., Agilent Technologies, Inc., bioMérieux, Inc., Alere, Inc.

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


Report Scope:

In this report, the Global Therapeutic Drug Monitoring Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  • Global Therapeutic Drug Monitoring Market, By Product:
    • Consumables
    • Equipment’s
    • Immunoassay Analyzers
    • Chromatography & MS Detector
    • Clinical Chemistry Analyzers
  • Global Therapeutic Drug Monitoring Market, By Technology:
    • Immunoassay
    • Chemiluminescence Immunoassay
    • Colorimetric Immunoassay
    • Fluorescence
    • Immunoassay
    • Radioimmunoassay
    • others Immunoassay
    • chromatography-MS
    • LC-MS
    • GC-MS
  • Global Therapeutic Drug Monitoring Market, By Class of Drug
    • Antiepileptic Drug
    • Antibiotic Drug
    • Immunosuppressant Drug
    • Antiarrhythmic Drug
    • Bronchodilator Drug
    • Psychoactive Drug
    • Others
  • Global Therapeutic Drug Monitoring Market, By Class of Drug
    • Hospital Lab
    • Commercial & Private Lab
    • others
  • Global Therapeutic Drug Monitoring Market, By Region:
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • United Kingdom
      • Italy
      • Spain
    • Asia-Pacific
      • China
      • India
      • Japan
      • South Korea
      • Australia
    • South America
      • Brazil
      • Argentina
      • Colombia
    • Middle East & Africa

§  UAE

§  South Arabia

§  Saudi Africa

§  Turkey

§  Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Therapeutic Drug Monitoring Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Global Therapeutic Drug Monitoring Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.     Markets Covered

1.2.2.     Years Considered for Study

1.2.3.     Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, and Trends

4.    Voice of Customer

5.    Global Therapeutic Drug Monitoring Market Outlook

5.1.  Market Size & Forecast

5.1.1.     By Value

5.2.  Market Share & Forecast

5.2.1.     By Product (Consumables, Equipment’s, Immunoassay Analyzers, Chromatography & MS Detector, Clinical Chemistry Analyzers)

5.2.2.     By Technology (Immunoassay, Chemiluminescence Immunoassay, Colorimetric Immunoassay, Fluorescence, Immunoassay, Radioimmunoassay, others Immunoassay, chromatography-MS, LC-MS, GC-MS)

5.2.3.     By Class of Drug (Antiepileptic Drug, Antibiotic Drug, Immunosuppressant Drug, Antiarrhythmic Drug, Bronchodilator Drug, Psychoactive Drug, and others)

5.2.4.     By End User (Hospital Lab, Commercial & Private Lab, others)

5.2.5.     By Region

5.2.6.     By Company (2022)

5.3.  Product Map

5.3.1.     By Type

5.3.2.     By End-use

6.    North America Therapeutic Drug Monitoring Market Outlook

6.1.  Market Size & Forecast          

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Product (Consumables, Equipment’s, Immunoassay Analyzers, Chromatography & MS Detector, Clinical Chemistry Analyzers)

6.2.2.     By Technology (Immunoassay, Chemiluminescence Immunoassay, Colorimetric Immunoassay, Fluorescence, Immunoassay, Radioimmunoassay, others Immunoassay, chromatography-MS, LC-MS, GC-MS)

6.2.3.     By Class of Drug (Antiepileptic Drug, Antibiotic Drug, Immunosuppressant Drug, Antiarrhythmic Drug, Bronchodilator Drug, Psychoactive Drug, and others)

6.2.4.     By End User (Hospital Lab, Commercial & Private Lab, others)

6.2.5.     By Country

6.3.  North America: Country Analysis

6.3.1.     United States Therapeutic Drug Monitoring Market Outlook

6.3.1.1.         Market Size & Forecast

6.3.1.1.1.             By Value

6.3.1.2.         Market Share & Forecast

6.3.1.2.1.             By Product

6.3.1.2.2.             By Technology

6.3.1.2.3.             By class of Drug

6.3.1.2.4.             By End- User

6.3.2.     Canada Therapeutic Drug Monitoring Market Outlook

6.3.2.1.         Market Size & Forecast

6.3.2.1.1.             By Value

6.3.2.2.         Market Share & Forecast

6.3.2.2.1.             By Product

6.3.2.2.2.             By Technology

6.3.2.2.3.             By class of Drug

6.3.2.2.4.             By End- User

6.3.3.     Mexico Therapeutic Drug Monitoring Market Outlook

6.3.3.1.         Market Size & Forecast

6.3.3.1.1.             By Value

6.3.3.2.         Market Share & Forecast

6.3.3.2.1.             By Product

6.3.3.2.2.             By Technology

6.3.3.2.3.             By class of Drug

6.3.3.2.4.             By End- User

7.    Europe Therapeutic Drug Monitoring Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Product (Consumables, Equipment’s, Immunoassay Analyzers, Chromatography & MS Detector, Clinical Chemistry Analyzers)

7.2.2.     By Technology (Immunoassay, Chemiluminescence Immunoassay, Colorimetric Immunoassay, Fluorescence, Immunoassay, Radioimmunoassay, others Immunoassay, chromatography-MS, LC-MS, GC-MS)

7.2.3.     By Class of Drug (Antiepileptic Drug, Antibiotic Drug, Immunosuppressant Drug, Antiarrhythmic Drug, Bronchodilator Drug, Psychoactive Drug, and others)

7.2.4.     By End User (Hospital Lab, Commercial & Private Lab, others)

7.2.5.     By Country

7.3.  Europe: Country Analysis

7.3.1.     France Therapeutic Drug Monitoring Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Product

7.3.1.2.2.             By Technology

7.3.1.2.3.             By class of Drug

7.3.1.2.4.             By End- User

7.3.2.     United Kingdom Therapeutic Drug Monitoring Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Product

7.3.2.2.2.             By Technology

7.3.2.2.3.             By class of Drug

7.3.2.2.4.             By End- User

7.3.3.     Italy Therapeutic Drug Monitoring Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Product

7.3.3.2.2.             By Technology

7.3.3.2.3.             By class of Drug

7.3.3.2.4.             By End- User